Nova Eye Medical Future Growth

Future criteria checks 6/6

Nova Eye Medical is forecast to grow earnings and revenue by 102.3% and 26.3% per annum respectively. EPS is expected to grow by 101.6% per annum. Return on equity is forecast to be 28.9% in 3 years.

Key information

102.3%

Earnings growth rate

101.6%

EPS growth rate

Medical Equipment earnings growth16.2%
Revenue growth rate26.3%
Future return on equity28.9%
Analyst coverage

Low

Last updated25 Nov 2024

Recent future growth updates

Recent updates

We Think Nova Eye Medical (ASX:EYE) Can Afford To Drive Business Growth

Nov 04
We Think Nova Eye Medical (ASX:EYE) Can Afford To Drive Business Growth

Nova Eye Medical Limited (ASX:EYE) Might Not Be As Mispriced As It Looks After Plunging 26%

Sep 22
Nova Eye Medical Limited (ASX:EYE) Might Not Be As Mispriced As It Looks After Plunging 26%

Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)

Aug 06
Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)

Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward

Apr 18
Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward

Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?

Mar 26
Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?

News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts

Jan 19
News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts

Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce

Dec 27
Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce

We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate

Sep 03
We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate

Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified

Apr 17
Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified

Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?

Dec 16
Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?

We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully

Aug 27
We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully

Earnings and Revenue Growth Forecasts

ASX:EYE - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2027536572
6/30/2026421022
6/30/202532-3-3-12
6/30/202423-9-8-8N/A
3/31/202421-12-8-7N/A
12/31/202319-14-7-6N/A
9/30/202318-15-7-7N/A
6/30/202317-15-8-7N/A
3/31/202316-13-9-8N/A
12/31/202215-11-10-9N/A
9/30/202214-9-10-7N/A
6/30/202213-7-10-5N/A
3/31/202213-7-13-8N/A
12/31/202113-6-16-11N/A
9/30/202113-5-16-12N/A
6/30/202113-4-15-13N/A
12/31/202012-9-10N/A
9/30/202013-1023N/A
6/30/202013-1045N/A
12/31/201916-6-4-1N/A
9/30/201916-6-6-2N/A
6/30/201916-7-8-4N/A
3/31/201948-7-7-2N/A
12/31/201849-6-6-1N/A
9/30/201864-6-60N/A
6/30/201879-5-61N/A
3/31/201877-5N/A-2N/A
12/31/201775-5N/A-4N/A
9/30/201773-3N/A-4N/A
6/30/201772-1N/A-3N/A
3/31/2017721N/A-1N/A
12/31/2016733N/A2N/A
9/30/2016733N/A3N/A
6/30/2016733N/A5N/A
3/31/2016703N/A6N/A
12/31/2015672N/A7N/A
9/30/2015652N/A7N/A
6/30/2015632N/A7N/A
3/31/2015611N/A5N/A
12/31/2014591N/A4N/A
9/30/2014571N/A3N/A
6/30/2014541N/A3N/A
3/31/2014510N/A2N/A
12/31/201347-1N/A2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: EYE is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: EYE is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: EYE is expected to become profitable in the next 3 years.

Revenue vs Market: EYE's revenue (26.3% per year) is forecast to grow faster than the Australian market (5.7% per year).

High Growth Revenue: EYE's revenue (26.3% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: EYE's Return on Equity is forecast to be high in 3 years time (28.9%)


Discover growth companies